Neurocrine Biosciences In...

NASDAQ: NBIX · Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM

Neurocrine Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
233M 251.1M 262.9M 340.8M
Short-Term Investments
843.1M 780.5M 726.4M 370.5M
Long-Term Investments
864.3M 849.4M 401.5M 624.4M
Other Long-Term Assets
15.5M 49.6M 25M 4.4M
Receivables
479.1M 439.3M 350M 185.5M
Inventory
57.4M 38.3M 35.1M 30.5M
Other Current Assets
112.1M 97.8M 79.1M 45.5M
Total Current Assets
1.72B 1.61B 1.45B 972.8M
Property-Plant & Equipment
592M 347.3M 145.6M 155.8M
Goodwill & Intangibles
36.5M 35.5M 37.2M n/a
Total Long-Term Assets
1.99B 1.64B 915.2M 1.1B
Total Assets
3.72B 3.25B 2.37B 2.07B
Account Payables
110M 108.9M 67.3M 51.5M
Deferred Revenue
n/a n/a n/a -16.5M
Short-Term Debt
n/a 170.1M 169.4M n/a
Other Current Liabilities
397.7M 285.8M 29.7M 82.7M
Total Current Liabilities
507.7M 654.8M 537.7M 245.8M
Long-Term Debt
n/a n/a n/a 335.1M
Other Long-Term Liabilities
621.3M 106.3M 29.7M 12.3M
Total Long-Term Liabilities
621.3M 364.6M 123.2M 452.7M
Total Liabilities
1.13B 1.02B 660.9M 698.5M
Total Debt
455.1M 428.4M 262.9M 440.4M
Common Stock
100K 100K 100K 100K
Retained Earnings
29.2M -157.1M -406.8M -635.8M
Comprehensive Income
5.8M 7M -7.9M -1.7M
Shareholders Equity
2.59B 2.23B 1.71B 1.37B
Total Investments
1.71B 1.63B 1.13B 994.9M